MARKET

KERN

KERN

Akerna Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.710
-0.580
-13.52%
Pre Market: 3.760 +0.05 +1.35% 04:51 12/02 EST
OPEN
4.380
PREV CLOSE
4.290
HIGH
4.390
LOW
3.710
VOLUME
235
TURNOVER
--
52 WEEK HIGH
13.50
52 WEEK LOW
2.170
MARKET CAP
73.03M
P/E (TTM)
-2.6810
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Top ETF of November & Its Best Stocks
Amplify Seymour Cannabis ETF (CNBS) topped the list of the best-performing ETFs of November with impressive returns of more than 47%.
Zacks · 16h ago
NIO Limited, XPeng among major consumer cyclical premarket losers' pack
Hepion Pharmaceuticals (HEPA)-28% after prices equity offering at $1.50.Fuel Tech (FTEK) -25%.ECMOHO (MOHO) -24%.Ideanomics (IDEX) -17%.Nikola (NKLA) -15% on concerns over GM deal, gauntlet of stock.Blink Charging (BLNK) -12%.Li Auto (LI) -12%  Chinese EV stocks
Seekingalpha · 6d ago
Where Do Hedge Funds Stand On Akerna Corp. (KERN)?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […]
Insider Monkey · 11/25 04:22
ACB, RIG, CLNE and MARA among premarket gainers
Fuel Tech (FTEK) +115%.SPI Energy (SPI) +64% as company delivers two electric shuttle buses to the city of Santa Cruz.The Goldfield (GV) +63% as company to be acquired by First Reserve for $7.00 per
Seekingalpha · 11/24 13:24
Cannabis Sales Expected to Reach Approximately $270M Over Thanksgiving Weekend
New business intelligence from Akerna (Nasdaq: KERN), an enterprise software, leading compliance technology provider, and developer of the cannabis industry's first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), anticipates a 78% increase over average daily sales for 2020 during the Thanksgiving weekend (11/25 – 11/28), totaling approximately $270 million.
PR Newswire · 11/19 16:23
Akerna CEO Shares Data Insights On Relationship Between Medicinal & Adult-Use Cannabis Markets
This special presentation from Akerna comes from Benzinga's Virtual Cannabis Capital Conference that took place on October 15. Click here for more coverage of this event with presentations from some of the top CEOs, investors and lenders in the cannabis space.At Benzinga's most recent Cannabis Capital Conference, Akerna Corp (NASDAQ: KERN) CEO Jessica Billingsley announced the recent launch of the company's new product MJ Retail. MJ Retail is an independent, point of sale product that is designed specifically to provide merchants and consumers with flexible and mobile-friendly experiences by allowing transactions to happen at any time throughout the retail experience. "MJ Retail marries both form and function," began Billingsley, "and it doesn't sacrifice critical data collection and analytics reporting features."Medical & Adult-Use In addition to their new product announcement, Billingsley shared some data-specific insights on the symbiotic nature of medical and adult-use cannabis markets.Looking at 2012 data when Colorado first legalized adult-use marijuana, many thought it would be the end of the medical market. Although 8 years later, the opposite proved true. "While medical sales initially plateau following the passage of adult-use, after about 6 months medical and adult-use both begin to increase in a symbiotic way," said Billingsley. "We believe this may be the result of adult-use consumers enjoying health and wellness benefits from the product and converting to medical patients."The Data Akerna publishes regular flash reports that provide data on consumer purchasing behavior. The report is a useful and free resource for anyone in the cannabis industry.According to data pulled from Akerna's flash reports, medical patients spend more and purchase more items than their adult-use counterparts. The average spend per transaction for medical use patients is $120 while the average transaction amount for adult-use is closer to $70. "Nearly half of cannabis users are above the age of 40," said Billingsley. "When folks are thinking about marketing and marketing to younger folks, it's a reminder that half the market is in a different age demographic."Lastly, the flash report's data demonstrated that vapes in both medical and adult-use are the preferred method of consumption. Although, it is more dominant in medical-use. "Flower dominants both markets, but when you look at all of the other manufactured products, vaporizers are the number one with medical being higher than adult-use."Photo by Marco Jimenez on UnsplashSee more from Benzinga * Click here for options trades from Benzinga * Meet iFlip, A 2020 Benzinga Global Fintech Awards Finalist * Meet Mythic Markets, A 2020 Benzinga Global Fintech Awards Finalist(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga · 11/16 16:16
The Week In Cannabis: Stocks Down Amid Earnings Season, Argentina Regulates Medical Marijuana
Cannabis stocks were back in the red this week, retreating from post-election highs amid an earnings-heavy period. Over the five trading days of the week:
Benzinga · 11/14 17:49
Akerna: Q1 Earnings Insights
Shares of Akerna (NASDAQ:KERN) decreased 3.2% in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share fell 61.90% year over year to ($0.34), which missed the estimate of ($0.28).Revenue of $3,714,000 higher by 16.32% year over year, which missed the estimate of $4,490,000.Guidance Akerna hasn't issued any earnings guidance for the time being.Akerna hasn't issued any revenue guidance for the time being.Conference Call Details Date: Nov 12, 2020View more earnings on KERNTime: 08:30 AMET Webcast URL: https://ir.akerna.com/news-events/ir-calendar/detail/6766/q1-2021-earnings-callPrice Action 52-week high: $13.5052-week low: $2.17Price action over last quarter: down 16.76%Company Overview Akerna Corp is a United States-based company. The firm is the first compliance technology company in the cannabis space. It offers MJ Platform and Leaf Data Systems which are platforms that provide clients and government entities with a central data management system for tracking regulated cannabis products from seed to product to shelf to customers through the supply chain. The company generates the majority of the revenue from its commercial software platforms.See more from Benzinga * Click here for options trades from Benzinga * Earnings Scheduled For November 12, 2020 * 12 Healthcare Stocks Moving In Friday's Intraday Session(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga · 11/12 12:06
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of KERN. Analyze the recent business situations of Akerna Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average KERN stock price target is 8.00 with a high estimate of 8.00 and a low estimate of 8.00.
EPS
Institutional Holdings
Institutions: 55
Institutional Holdings: 1.89M
% Owned: 9.60%
Shares Outstanding: 19.69M
TypeInstitutionsShares
Increased
13
446.87K
New
13
-59.27K
Decreased
11
52.63K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
IT Services & Consulting
-0.47%
Software & IT Services
+0.57%
Key Executives
Chairman/Director
Steven Van Dyke
Chairman/Chief Executive Officer/Director
Jessica Billingsley
Chief Financial Officer/Secretary
John Fowle
Chief Technology Officer
David McCullough
Independent Director
W. Jake Bergmann
Other
Nina Simosko
Independent Director
Anthony Georgiadis
Other
Ray Thompson
Director
Scott Sozio
Independent Director
Emily Paxhia
Independent Director
Mark Iwanowski
Independent Director
Matthew Kane
Independent Director
Tahira Rehmatullah
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About KERN
Akerna Corp. is a cannabis compliance, inventory tracking technology, and provider of the cannabis enterprise resource planning technology. Its products enable cannabis businesses and government agencies across multiple industries and geographies to compliantly manage the cannabis supply chain from seed-to-sale and collect and synthesize valuable data to enable visibility and operations management at scale. The Company provides its regulatory software platform, Leaf Data Systems, to state government regulatory agencies, and its business software platform, MJ Platform, to state-licensed businesses. Its core products, Leaf Data Systems and MJ Platform, are versatile platforms that provide its clients with a central data management system for tracking regulated products from seed to initial plant growth to product throughout the complete supply chain. Its platforms also provide clients with integrated security, transparency and scalability capabilities.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Akerna Corp stock information, including NASDAQ:KERN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KERN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading KERN stock methods without spending real money on the virtual paper trading platform.